Institute of Personalized Medicine - PUMA IPM
Pharmacogenomics aims at understanding how variations in the human genome affect the response to medications.
Our researchers are working to generate new knowledge, and to develop tools and algorithms that can help in personalizing medicine utilizing a patient’s genetic profile and other factors to achieve maximum therapeutic benefit with minimum toxicity.
Cathy McCarty was the Principal Investigator for the Marshfield Clinic Personalized Medicine Research Project, with more than twenty genetic epidemiology and pharmacogenetic studies of metformin, coumadin and ACE inhibitors. She is currently collaborating with Dr.
A College of Pharmacy internal grant has been awarded to the project, "Enhance Comprehensive Pharmacist Services to Improve Patient Health: Creating a 21 st Century Precision Medicine Intensive Care Unit (ICU)."
The focus of the project is on sedation in mechanically ventilated patients and it aims to identify actionable genetic variants in ICU patients and evaluate the relationship between genotypes and drug efficacy as well as adverse drug reactions (ADR) in a real-world setting at the bedside.
Dr. Zhang is an Assistant Professor in the Department of Pharmaceutical Care & Health System (PCHS) and the Institute for Health Informatics (IHI). He is also a faculty member in Data Science graduate program. Dr. Zhang has extensive education background and research experience in the field of health and biomedical informatics, especially biomedical natural language processing and text mining.
Weekly Genomics Scan
This weekly update features emerging roles of human genomics, testing and interventions in a wide variety of noncommunicable diseases across the life span.
University Precision Medicine Initiatives
Precision Medicine Seminar Series
Presented by The Minnesota Precision Medicine Collaborative
"Panel Discussion: A Vision for Precision Medicine in the AHC"